✦ LIBER ✦

Interferon and ribavirin cause significant side effects, but improve liver function in patients with recurrent hepatitis C following liver transplantation

✍ Scribed by Maureen Burke-Davis; James B Piper; James Lim; Judy Kovalak; David C Wolf

Book ID: 119389518
Publisher: Nature Publishing Group
Year: 2000
Tongue: English
Weight: 42 KB
Volume: 95
Category: Article
ISSN: 0002-9270
DOI: 10.1016/s0002-9270(00)01534-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of interferon treatment on liver

Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation

✍ R. Todd Stravitz; Mitchell L. Shiffman; Arun J. Sanyal; Velimir A. Luketic; Rich 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 938 KB

Recurrent hepatitis C after liver transplantation remains a significant cause of graft loss and retransplantation. Although treatment of recurrent hepatitis C with interferon-based regimens has become widely accepted as safe and can lead to sustained virologic clearance of hepatitis C virus (HCV) RN

Impact of Pegylated Interferon and Ribav

Impact of Pegylated Interferon and Ribavirin Treatment on Graft Survival in Liver Transplant Patients with Recurrent Hepatitis C Infection

✍ B. J. Veldt; J. J. Poterucha; K. D. S. Watt; R. H. Wiesner; J. E. Hay; W. K. Kre 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Combination therapy/prophylaxis with int

Combination therapy/prophylaxis with interferon and ribavirin for recurrent hepatitis C after liver transplantation: long-term effects on graft function and morphology

✍ A Kornberg; M Hommann; A Tannapfel; T.h Grube; U Schotte; J Scheele 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Clinical significance of breakthrough ph

Clinical significance of breakthrough phenomenon in liver transplant patients with recurrent hepatitis C treated with interferon-ALPHA AND ribaviria

✍ Aejaz Nasir; Gregory A. Smallwood; Andrei C. Stieber; Thomas G. Heffron; Michael 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Efficacy and safety of pegylated interfe

Efficacy and safety of pegylated interferon plus ribavirin in patients with hepatitis C recurrence after liver transplantation: A single centre experience

✍ M.F. Donato; F. Agnelli; M. Vigano’; C. Rigamonti; G. Rossi; M. Colombo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

PA.110 FACTORS INFLUENCING SUSTAINED VIR

PA.110 FACTORS INFLUENCING SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION

✍ F. Gentili; S. Grieco; M. Giusto; I. Loria; M. Rossi; P. Berloco; G. Novelli; G. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB